Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
11.99
-0.04 (-0.33%)
At close: Apr 1, 2025, 4:00 PM
11.93
-0.06 (-0.49%)
After-hours: Apr 1, 2025, 4:20 PM EDT
Evolus Employees
Evolus had 332 employees as of December 31, 2024. The number of employees increased by 59 or 21.61% compared to the previous year.
Employees
332
Change (1Y)
59
Growth (1Y)
21.61%
Revenue / Employee
$802,030
Profits / Employee
-$151,867
Market Cap
762.41M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
EOLS News
- 7 days ago - Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference - Business Wire
- 11 days ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 27 days ago - Evolus, Inc. (EOLS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Evolus posts quarterly profit on strong sales of cosmetic injection - Reuters
- 27 days ago - Evolus Reports Record Fourth Quarter and Full-Year 2024 Financial Results; Reaffirms 2025 Guidance - Business Wire
- 4 weeks ago - Evolus to Participate in Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences - Business Wire
- 5 weeks ago - Evolus to Participate in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit - Business Wire
- 6 weeks ago - Evolus to Report Fourth Quarter and Year End 2024 Results on March 4, 2025 - Business Wire